After adjusting for confounding factors, patients with CSU experience worse health outcomes and quality of life than patients with AD or PsO.

The majority of patients with skin of color and scalp psoriasis who were treated with guselkumab achieved significant scalp clearance.

The UP-AA clinical program includes 2 studies assessing the safety and efficacy of upadacitinib in adults and adolescent patients with severe alopecia areata.

President Trump ordered the reinstatement of the Presidential Fitness Test program, which tests children's athletic abilities.

New research suggests that the survival benefits observed with different treatments for advanced melanoma vary according to the site of metastasis.

The FDA is updating opioid safety labels to support treatment decisions based on the latest evidence to reduce misuse.

A growing number of women with chronic inflammatory diseases are continuing to use TNF inhibitors throughout pregnancy.

An increase in the population burden of atopic dermatitis was associated with increased levels of environmental pollution and weather extremes.

Results of a systematic review and meta-analysis revealed that JIIMs may negatively impact growth and pubertal development.

More than half of pediatric patients with psoriasis or psoriasiform dermatitis had an anogenital or pharyngeal bacterial infection.

Adding polygenic scores to early-life body mass index up to age 5 improved body mass index prediction at age 18 years.

The risk for several ocular and auditory comorbidities is increased in children, adolescents, and adults with vitiligo compared with control patients.